Catalyst Wire Dossier Catalyst Wire Dossier

MB09

denosumab · mAbxience Research S.L.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MB09, covering 2025-01-03 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Efficacy, PK, PD, Safety and IMM of MB09 to Prolia® [EU-sourced] in Postmenopausal Osteoporosis. [Phase 3]

See pricing